SLC31A1 and cancer: However, for patients with high SLC31A1 expression, this phenomenon can be exploited to design copper-loaded nano-drugs for treatment, because cancer cells absorb such drugs significantly more easily than normal cells, which can improve cancer treatment by activating cuproptosis.